Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis

J Pediatr. 2002 Jan;140(1):125-7. doi: 10.1067/mpd.2002.120835.

Abstract

Systemic onset juvenile rheumatoid arthritis unresponsive to nonsteroidal anti-inflammatory drugs may be controlled with corticosteroids, but these drugs have significant side effects. We report 2 steroid-dependent children with systemic onset juvenile rheumatoid arthritis who did not respond to multiple nonsteroidal anti-inflammatory drugs, methotrexate, azathioprine, cyclosporine, and etanercept. Both children had significant improvement with thalidomide therapy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Humans
  • Male
  • Thalidomide / therapeutic use*

Substances

  • Thalidomide